Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the hypothesis that use of pharmacological and
non-pharmacological interventions may allow subjects at high risk for chronic migraine to
avoid or reverse the transformation of episodic migraine to chronic migraine.